A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia. Kadia TM, Jen WY, Bataller A, Bazinet A, et al. Am J Hematol 2025 May 22. doi: 10.1002/ajh.27723.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kadia TM, Jen WY, Bataller A, Bazinet A, et al. A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia. Am J Hematol 2025 May 22. doi: 10.1002/ajh.27723.
PMID: 40401707